Terms: = Leukemia AND CDX2, CDX3, 1045, ENSG00000165556, Q99626 AND Treatment
17 results:
1. Patient-reported patterns of follow-up care in the 'Aftercare in Blood Cancer Survivors' (ABC) study.
Baum J; Lax H; Lehmann N; Merkel-Jens A; Beelen DW; Jöckel KH; Dührsen U
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10531-10542. PubMed ID: 37291404
[TBL] [Abstract] [Full Text] [Related]
2. Design, synthesis and pharmacological characterization of aminopyrimidine derivatives as BTK/FLT3 dual-target inhibitors against acute myeloid leukemia.
Ran F; Liu Y; Zhu J; Deng X; Wu H; Tao W; Xie X; Hu Y; Zhang Y; Ling Y
Bioorg Chem; 2023 May; 134():106479. PubMed ID: 36989958
[TBL] [Abstract] [Full Text] [Related]
3. Concurrent cdx2 cis-deregulation and UBTF::ATXN7L3 fusion define a novel high-risk subtype of B-cell ALL.
Passet M; Kim R; Gachet S; Sigaux F; Chaumeil J; Galland A; Sexton T; Quentin S; Hernandez L; Larcher L; Bergugnat H; Ye T; Karasu N; Caye A; Heizmann B; Duluc I; Chevallier P; Rousselot P; Huguet F; Leguay T; Hunault M; Pflumio F; Freund JN; Lobry C; Lhéritier V; Dombret H; Domon-Dell C; Soulier J; Boissel N; Clappier E
Blood; 2022 Jun; 139(24):3505-3518. PubMed ID: 35316324
[TBL] [Abstract] [Full Text] [Related]
4. [Expression of Hsa-miR-9 in Children with Acute Lymphoblastic leukemia and Its Relationship with cdx2 Gene].
Wang RC; Yang J; Zhang XX; Gao XH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Oct; 28(5):1523-1527. PubMed ID: 33067948
[TBL] [Abstract] [Full Text] [Related]
5. Hematopoietic stem and progenitor cell-restricted cdx2 expression induces transformation to myelodysplasia and acute leukemia.
Vu T; Straube J; Porter AH; Bywater M; Song A; Ling V; Cooper L; Pali G; Bruedigam C; Jacquelin S; Green J; Magor G; Perkins A; Chalk AM; Walkley CR; Heidel FH; Mukhopadhyay P; Cloonan N; Gröschel S; Mallm JP; Fröhling S; Scholl C; Lane SW
Nat Commun; 2020 Jun; 11(1):3021. PubMed ID: 32541670
[TBL] [Abstract] [Full Text] [Related]
6. The clinical significance of cdx2 in leukemia: A new perspective for leukemia research.
Darvishi M; Mashati P; Khosravi A
Leuk Res; 2018 Sep; 72():45-51. PubMed ID: 30096576
[TBL] [Abstract] [Full Text] [Related]
7. Novel roles of ginsenoside Rg3 in apoptosis through downregulation of epidermal growth factor receptor.
Joo EJ; Chun J; Ha YW; Ko HJ; Xu MY; Kim YS
Chem Biol Interact; 2015 May; 233():25-34. PubMed ID: 25824408
[TBL] [Abstract] [Full Text] [Related]
8. [Expression of cdx2 gene in pediatric patients with leukemia and its clinical significance].
Li YX; Pan KL; Fan F; Qian XH; Yang XL; Deng YL; Liu YD
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Feb; 19(1):130-3. PubMed ID: 21362237
[TBL] [Abstract] [Full Text] [Related]
9. Aberrant expression of the homeobox gene cdx2 in pediatric acute lymphoblastic leukemia.
Riedt T; Ebinger M; Salih HR; Tomiuk J; Handgretinger R; Kanz L; Grünebach F; Lengerke C
Blood; 2009 Apr; 113(17):4049-51. PubMed ID: 19218548
[TBL] [Abstract] [Full Text] [Related]
10. Cytogenetic, molecular genetic, and clinical characteristics of acute myeloid leukemia with a complex karyotype.
Mrózek K
Semin Oncol; 2008 Aug; 35(4):365-77. PubMed ID: 18692687
[TBL] [Abstract] [Full Text] [Related]
11. Expression of genes involved in early cell fate decisions in human embryos and their regulation by growth factors.
Kimber SJ; Sneddon SF; Bloor DJ; El-Bareg AM; Hawkhead JA; Metcalfe AD; Houghton FD; Leese HJ; Rutherford A; Lieberman BA; Brison DR
Reproduction; 2008 May; 135(5):635-47. PubMed ID: 18411410
[TBL] [Abstract] [Full Text] [Related]
12. Copy number alterations in childhood acute lymphoblastic leukemia and their association with minimal residual disease.
Steinemann D; Cario G; Stanulla M; Karawajew L; Tauscher M; Weigmann A; Göhring G; Ludwig WD; Harbott J; Radlwimmer B; Bartram C; Lichter P; Schrappe M; Schlegelberger B
Genes Chromosomes Cancer; 2008 Jun; 47(6):471-80. PubMed ID: 18311775
[TBL] [Abstract] [Full Text] [Related]
13. Gene expression analysis of BCR/ABL1-dependent transcriptional response reveals enrichment for genes involved in negative feedback regulation.
Håkansson P; Nilsson B; Andersson A; Lassen C; Gullberg U; Fioretos T
Genes Chromosomes Cancer; 2008 Apr; 47(4):267-75. PubMed ID: 18181176
[TBL] [Abstract] [Full Text] [Related]
14. Secondary leukemia after epirubicin-based adjuvant chemotherapy in operable breast cancer patients: 16 years experience of the French Adjuvant Study Group.
Campone M; Roché H; Kerbrat P; Bonneterre J; Romestaing P; Fargeot P; Namer M; Monnier A; Montcuquet P; Goudier MJ; Fumoleau P
Ann Oncol; 2005 Aug; 16(8):1343-51. PubMed ID: 15905306
[TBL] [Abstract] [Full Text] [Related]
15. Apoptosis- and necrosis-inducing potential of cladribine, cytarabine, cisplatin, and 5-fluorouracil in vitro: a quantitative pharmacodynamic model.
Guchelaar HJ; Vermes I; Koopmans RP; Reutelingsperger CP; Haanen C
Cancer Chemother Pharmacol; 1998; 42(1):77-83. PubMed ID: 9619762
[TBL] [Abstract] [Full Text] [Related]
16. Acute nonlymphocytic leukemia: onset after treatment for Hodgkin's disease.
Maurizi Enrici R; Anselmo AP; Osti MF; Santoro M; Sbarbati S; Tombolini V; Mandelli F; D'Arcangelo E; Biagini C
Ann Hematol; 1997 Mar; 74(3):103-10. PubMed ID: 9111422
[TBL] [Abstract] [Full Text] [Related]
17. High risk of streptococcal septicemia after high dose cytosine arabinoside treatment for acute myelogenous leukemia.
Kern W; Kurrle E; Vanek E
Klin Wochenschr; 1987 Aug; 65(16):773-80. PubMed ID: 3477669
[TBL] [Abstract] [Full Text] [Related]
